Hims & Hers Health, Inc. (HIMS) insider details RSU vesting, 164,369 shares
Rhea-AI Filing Summary
Hims & Hers Health, Inc. reported insider equity activity by its chief executive officer, who is also a director and 10% owner, on December 15, 2025. The filing shows the acquisition of 164,369 shares of Class A Common Stock through the settlement of restricted stock units.
On the same date, 90,660 shares of Class A Common Stock were disposed of at $36.25 per share, as the issuer withheld these shares to cover tax withholding obligations related to the RSU vesting. Following these transactions, the reporting person held 878,732 Class A shares directly, in addition to substantial indirect holdings through multiple family trusts.
The RSU awards each convert into one share of Class A Common Stock and are subject to four-year, service-based vesting in substantially equal quarterly installments on Company Quarterly Vesting Dates. Depending on the grant, these quarterly vesting schedules began on June 15, 2022, June 15, 2023, June 15, 2024 and June 15, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 35,242 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 35,446 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 74,530 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 19,151 | $0.00 | -- |
| Exercise | Class A Common Stock | 164,369 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 90,660 | $36.25 | $3.29M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
FAQ
What insider transaction did Hims & Hers Health (HIMS) report here?
The report shows that on December 15, 2025, the chief executive officer, who is also a director and 10% owner, acquired 164,369 shares of Hims & Hers Class A Common Stock through the settlement of restricted stock units and had shares withheld to cover taxes.
What are the vesting terms of the Hims & Hers RSUs in this report?
The restricted stock units represent a contingent right to receive one Class A share per RSU. They are subject to service-based vesting over four-year periods, vesting in substantially equal quarterly installments on Company Quarterly Vesting Dates of March 15, June 15, September 15 and December 15, with first vesting dates on June 15, 2022, June 15, 2023, June 15, 2024 and June 15, 2025, depending on the grant.
How many restricted stock units remain outstanding for the Hims & Hers CEO?
After the reported transactions, remaining RSU balances included 35,242, 177,233, 670,769 and 248,955 restricted stock units, each RSU representing the right to receive one share of Class A Common Stock upon vesting and settlement.
What roles does the reporting person hold at Hims & Hers Health, Inc.?
The reporting person is identified as a Director, a 10% Owner, and an Officer of Hims & Hers Health, Inc., serving as Chief Executive Officer.